HomeNews & TopicsSurgeryLondon Health Sciences Centre reduces cancer surgery wait times by 50 per...

London Health Sciences Centre reduces cancer surgery wait times by 50 per cent

Published on

Through several focused strategies and a dedicated team effort, London Health Sciences Centre (LHSC) has improved cancer surgery wait times at the Verspeeten Family Cancer Centre by 50 per cent over the past year for non-urgent and non-emergent patients. 

“We know how hard it is for patients with cancer and their families to wait for surgery and we needed to do everything we could to improve our times,” says Dr. Michael Ott, Department Head, Oncology, LHSC. “This involved finding new ways to maximize our current resources and improve efficiencies – like improving our referral systems, optimizing our data used in making decisions, and dedicating more operating room time for cancer surgeries.” 

The impact of these efforts is clear. As of March 2024, 90 per cent of all oncology patients receive their surgery within the targeted wait time, according to the urgency of their diagnosis.   

Dr. Ott notes that, “We won’t settle until every patient gets care within the appropriate target wait time, and we continue to improve.” 

While patients identified as high priority have largely been seen within the recommended surgical wait time, this reduction in wait times is even more impactful because these improvements positively impact patients who are more likely to encounter extended waits across the health-care system. 

“These improvements reflect our commitment to providing timely and efficient care to a growing number of patients across southwestern Ontario,” says Dr. Kevin Chan, Corporate Medical Executive, LHSC.   

LHSC is home to the regional cancer centre responsible for providing inpatient and outpatient cancer care, including surgery, radiation therapy and chemotherapy, as well as a full range of support services and the advancement of groundbreaking research. We remain committed to investing resources to further enhance the patient experience – from diagnosis to treatment.

Latest articles

A simple blood test can predict Crohn’s disease before symptoms appear

HN Summary• Sinai Health researchers have shown a simple blood test can predict Crohn’s...

Shorter duration of antimicrobial therapy in common infections

HN Summary• Growing evidence shows that shorter courses of antibiotics are just as effective...

Growing pressures facing hospital sector

At recent  2026/27 Pre-Budget Consultations, held by the Ministry of Finance in North York,...

Global clinical trial exploring potential treatment for sickle cell disease

HN Summary• SHN is leading a global clinical trial testing tebapivat, an investigational oral...

More like this

Global clinical trial exploring potential treatment for sickle cell disease

HN Summary• SHN is leading a global clinical trial testing tebapivat, an investigational oral...

Are we entering a new era of dementia treatment?

A Q&A with Sunnybrook Neurologists Over the next five years, researchers estimate that more than...

Lithium study yields insights in the fight against HIV

Study in human cells finds low-cost drug keeps virus dormant through an unexpected pathway,...

Gene mutation in blood-forming cells may improve cancer immunotherapy results

Researchers at UHN’s Princess Margaret Cancer Centre have found that inactivation of the TET2...

HHS one of new hospitals nationwide treating the heart with radiation

HN Summary• Innovative, non-invasive heart treatment: Hamilton Health Sciences is among a small number...

One-in-four children with major traumatic injuries not cared for in pediatric trauma centres

New research shows that 1 in 4 children with major traumatic injury do not...